Assignee
KARYOPHARM THERAPEUTICS INC
US·38 granted patents·15 pending applications·482 citations·filing 2013–2025
Top patents by PatentIndex Score
53 records- 0198US11807629B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Nov 7, 2023·6 cites·7 claims
- 0298US11787771B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·5 cites·12 claims
- 0398US11753401B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 12, 2023·5 cites·23 claims
- 0498US11746102B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 5, 2023·5 cites·17 claims
- 0597US12291508B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted May 6, 2025·2 cites·15 claims
- 0697US11078190B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·11 cites·20 claims
- 0797US11034660B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 0897US10519139B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 31, 2019·17 cites·28 claims
- 0997US10173987B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·18 cites·12 claims
- 1097US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 1197US9714226B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·28 cites·8 claims
- 1297US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 1397US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 1497US9206158B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·28 cites·2 claims
- 1597US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 1697US8999996B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·44 cites·2 claims
- 1796US10544108B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·14 cites·7 claims
- 1895US11945794B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·4 cites·18 claims
- 1995US11124493B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·12 cites·10 claims
- 2094US10709706B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 14, 2020·11 cites·34 claims
- 2194US10407405B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·21 cites·19 claims
- 2293US12371420B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·1 cites·14 claims
- 2393US9738624B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·29 cites·19 claims
- 2493US9550757B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Jan 24, 2017·24 cites·25 claims
- 2592US10202366B2Methods of promoting wound healing using CRM1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Feb 12, 2019·22 cites·6 claims
- 2691US10526295B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jan 7, 2020·12 cites·20 claims
- 2788US10399963B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·5 cites·17 claims
- 2887US9994558B2Multicyclic compounds and methods of using sameKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·6 cites·17 claims
- 2987US9856241B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2018·8 cites·16 claims
- 3086US12577225B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2024·Granted Mar 17, 2026·0 cites·17 claims
- 3186US11008309B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·20 claims
- 3285US10363247B2(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancerKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 30, 2019·5 cites·15 claims
- 3383US2024376114A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3482US9938258B2Substituted 2,3-dihydrobenzofuranyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Apr 10, 2018·6 cites·12 claims
- 3581US2026062391A1Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3680US2026085064A1Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3774US12331040B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·31 claims
- 3872US2022056038A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3970US10858347B2Multicyclic compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Dec 8, 2020·1 cites·31 claims
- 4066US2022168393A1Il-12 compositions and methods of use in hematopoietic recoveryKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4163US2020087313A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4260US12559478B2Co-crystal forms of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Feb 24, 2026·0 cites·19 claims
- 4358US12318386B2Combination of XPO1 inhibitors and second agents for the treatment of prostate cancerKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 3, 2025·0 cites·8 claims
- 4458US2024287041A1Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline formsKARYOPHARM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4557US2017137430A1Nuclear Transport Modulators And Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4654US12479806B2Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
- 4749US2023391754A1Crystalline form of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4846US2022178927A1Biomarkers for selinexorKARYOPHARM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4942US2016016916A1Exo Olefin-Containing Nuclear Transport Modulators and Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5038US2019218207A13-(Pyridin-3-yl)-Acrylamide and N-(Pyridin-3-yl)-Acrylamide Derivatives and Their Use as PAK or NAMPT ModulatorsKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →